Summary

  • FY26 total revenue of £4.626m included £0.400m of grant income; operating sales were £4.226m, of which £2.038m came from the Bridgestone iTrack royalty.
  • To exceed 25% total-revenue growth in FY27, Transense needs a steep rise in SAWsense and Translogik sales while protecting cash ahead of another royalty-rate reduction in FY28.

The headline mixes three different kinds of income

Transense reported £4.626m of total revenue for the year to June 2026, down 17%. That figure is useful only after it is disassembled. Customer and royalty sales were £4.226m; a further £0.400m was grant income. Within sales, Translogik produced £1.261m, SAWsense £0.927m and the Bridgestone iTrack licence £2.038m.

This distinction changes the reading of SAWsense. Its reported contribution was £1.327m, up 20%, but £0.400m of that was grant support. Commercial sales were £0.927m. Grants can properly reimburse funded work and reduce the cash cost of development. They are not evidence that customers are already ordering sensors in volume.

The royalty is different again. Transense sold the iTrack operating infrastructure to Bridgestone in 2020 and licensed the intellectual property for ten years. The resulting income carries very little segment cost: iTrack generated £1.994m of operating profit on £2.038m of revenue in FY26. It accounted for 44% of group revenue, down from 56% a year earlier, but remained the largest source of economic support.

A 25% group target implies a much larger operating-business hurdle

The board is aiming for total-revenue growth above 25% in FY27. The threshold is therefore more than £5.782m. The iTrack unit rate is unchanged for FY27, which temporarily protects the bridge. Yet the size of the bridge depends on volumes and sterling-dollar conversion, neither of which Transense controls.

A simple scenario shows the burden on the two operating businesses. If iTrack royalties remain at £2.038m and grant income remains £0.400m, SAWsense and Translogik commercial sales must together exceed £3.344m. They produced £2.188m in FY26. The implied increase is about 53%, not 25%.

That is not management guidance for each segment. Faster iTrack installations, a different exchange rate or a different level of grants would move the number. But it reveals why a list of prospective installations cannot be counted as revenue. FY26 underlying iTrack volume rose about 7%; royalties still fell 34% because the contracted unit rate dropped 40% and currency weakened.

The schedule tightens after FY27. The unit rate falls another 33% in FY28, to 40% of the original rate, and the licence ends in June 2030. Applying that cut mechanically to FY26 royalties would reduce them to roughly £1.37m before volume and currency changes. That is an illustration, not a forecast. It nevertheless defines the replacement task.

The £1.50m cash balance came with a financing footnote

Transense generated £0.885m of operating cash in FY26. It spent £0.533m on plant and equipment and £0.783m on intangible assets. Investment outflow was therefore £1.316m, greater than operating cash generation. A £0.967m asset-backed finance drawdown helped cash rise by £0.362m to £1.500m.

The company also reported net cash after asset-finance loans of £0.570m. The gross cash balance should not be read as a £1.50m pot available for discretionary expansion. It sits beside finance obligations, continuing development costs and a business whose adjusted profit before tax was only about £0.02m. Statutory operating loss was £0.086m and loss before tax £0.105m.

Segment economics show why capital allocation matters. Translogik made £0.403m of operating profit and iTrack £1.994m. SAWsense lost £0.788m at segment level, while unallocated costs were £1.695m. The newer activity is not yet financing itself.

Pilot production is a capability, not proof of volume

The investment is tangible. SAWsense's pilot production line at Weston on the Green is operating, and a £0.435m precision die-bonding machine supports repeatable placement of sensing elements. The line can demonstrate automated assembly and calibration, supply lower-volume motorsport or aerospace work, and help transfer a process to customers or Tier One suppliers for larger programmes.

That architecture can be capital-efficient if customers adopt it. Transense may earn from engineering, approved components and licences without owning every high-volume factory. It also shifts power to the customer's qualification timetable. A technically successful project can remain development income for a long period before becoming recurring production sales.

The same boundary applies to current announcements. Transense's role in the Cummins DriveSense project is valued at about £0.6m, but it is a funded development programme. Electric-drive, automation and robotics projects are intended for production in FY28; intention is not a purchase order. The Continental programme announced after year end is funded over six months and, subject to completion, is expected to generate more than £0.7m annually. It is commercially significant, but it was not FY26 revenue and its annual rate has not yet been realised.

Translogik's new distributors in North America, Europe and the Middle East widen access to fleets and tyre-service customers. They do not guarantee sell-through. The useful evidence will be repeat orders, software receipts and segment profit rather than the number of channel names.

Sources